ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. As of October 9, 2025, ESSA Pharma Inc. operates as a subsidiary of Alexis Bio, Inc.
Frequently asked questions
What sector does ESSA Pharma Inc (EPIX) operate in?
ESSA Pharma Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is ESSA Pharma Inc (EPIX) current stock price?
As of the latest data, ESSA Pharma Inc stock price is $0.20, with a previous close of $0.20.
What is ESSA Pharma Inc (EPIX) current market capitalization?
ESSA Pharma Inc market cap is approximately 9.52 million.
What is ESSA Pharma Inc (EPIX) Earnings Per Share (EPS)?
The trailing EPS is -$0.57, and the forward EPS is -$0.70.
Does ESSA Pharma Inc (EPIX) pay dividends?
Yes. ESSA Pharma Inc pays other dividends with an annualized yield of 839.96% and an estimated annual payout of $1.69 per share.
What is ESSA Pharma Inc (EPIX) beta (volatility) score?
ESSA Pharma Inc has a beta of 1.527, suggesting it is more volatile than the market.